Stay updated on GB002 Open-Label Extension in PAH Clinical Trial
Sign up to get notified when there's something new on the GB002 Open-Label Extension in PAH Clinical Trial page.

Latest updates to the GB002 Open-Label Extension in PAH Clinical Trial page
- Check5 days agoChange DetectedNo changes detected on the page. The content appears unchanged.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5 on the page, signaling a new revision of the page metadata. This change does not alter the study information or layout.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedSponsor information updated to Gossamer Bio USA, Inc., replacing GB002, Inc. and related subsidiary wording. The revision now shows v3.6.4 with dates in July 2026.SummaryDifference0.4%

- Check41 days agoChange DetectedThe sponsor/affiliations section was updated to reflect GB002, Inc.'s parent company as Gossamer Bio USA, Inc., replacing references to Gossamer Bio Inc. This change represents a corporate name update for the sponsor organization in the study record.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page content remains the same as in the prior version. No textual changes were detected in the reported update.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page revision label was updated from v3.6.2 to v3.6.3, indicating a small internal update to the study record page.SummaryDifference0.0%

Stay in the know with updates to GB002 Open-Label Extension in PAH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GB002 Open-Label Extension in PAH Clinical Trial page.